SCHEMBL6380649

SCHEMBL6380649

O=[C]OCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ RAB9A P51151 8/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ MAPT P10636 1/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ TSHR P16473 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ GLS O94925 1/20 0.52
▸ CASP3 P42574 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ KMT2A Q03164 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ GLA P06280 1/20 0.48
▸ BRCA1 P38398 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9596644 0.81 CA12 (0.46) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL8059321 0.81 HPGD (0.54) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL25991266 0.80 HPGD (0.61) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL2743018 0.80 HPGD (0.61) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL8862940 0.79 GAA (0.60) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL8862856 0.79 GAA (0.60) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL8862746 0.79 GAA (0.60) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL7519591 0.79 GAA (0.60) HPGDNPSR1RAB9ASMN1; SMN2MAPT
SCHEMBL6699936 0.77 GLS (0.71) RAB9ASMN1; SMN2MAPTNPC1GLS
SCHEMBL23791105 0.77 HPGD (0.57) HPGDNPSR1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882048-B1 3-ALKYLIMIDAZOPYRIDINES ALTANA PHARMA AG (DE) 2005-05-04 — — EP disclosed
US-6096758-A 3-METHYLIMIDAZOPYRIDINES USED FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-08-01 — — US disclosed
EP-0882048-A1 3-METHYLIMIDAZOPYRIDINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1998-12-09 — — EP disclosed
WO-1997027193-A1 IMIDAZOPYRIDINE HALIDES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1997-07-31 — — WO disclosed
WO-1997027192-A1 3-METHYLIMIDAZOPYRIDINES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1997-07-31 — — WO disclosed
Send feedback